Sensors from the FreeStyle Libre 2 and Libre 3 continuous glucose monitoring systems can now be worn during X-rays, CT scans and MRI scans. The news represents a shift in policy from the FDA, one that came after the agency reviewed extensive testing data.

Another MAC has agreed to cover the use of these advanced technologies to evaluate patients for signs of coronary artery disease. 

The shorter stay doesn't come at the expense of increased post-procedural complications, authors of a new analysis in JVIR recently shared.

The Obsidio Conformable Embolic is routinely used for vascular embolization procedures.

The premixed embolic agent is designed to embolize hypervascular tumors and occlude blood flow in a patient's peripheral blood vessels. It was recalled in April due to safety concerns.

Despite these incidents, CT continues to be the preferred imaging technology for patients with implantable or wearable medical devices.

Such technology can be leveraged to improve risk assessments without accruing additional expenses for patients or clinicians, potentially filling in gaps where DXA exams fall short.

Many of these files are still readily available online, and numerous contain PHI that is “easily accessible,” a new analysis reveals.